Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
100%(6 trials)

Phase Distribution

Ph phase_2
2
29%
Ph phase_1
1
14%
Ph phase_3
4
57%

Phase Distribution

1

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
4(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 34 (57.1%)

Trials by Status

completed686%
not_yet_recruiting114%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingphase_2

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

NCT06082817
completedphase_3

Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men

NCT01699178
completedphase_3

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

NCT01403116
completedphase_2

The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate

NCT02921386
completedphase_1

Phlebotomy Study of Testosterone Undecanoate

NCT02670343
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06082817Phase 2

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

Not Yet Recruiting
NCT01699178Phase 3

Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men

Completed
NCT01403116Phase 3

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Completed
NCT02921386Phase 2

The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate

Completed
NCT02670343Phase 1

Phlebotomy Study of Testosterone Undecanoate

Completed
NCT02722278Phase 3

A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Completed
NCT01765179Phase 3

Safety and Efficacy Trial of Testosterone Undecanoate

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7